Evidence map›Paper›PMID 25925501›Full record

SynthesisBritish journal of clinical pharmacology2015

Metformin versus insulin for gestational diabetes mellitus: a meta-analysis.

Li-Ping Zhao, Xiao-Yan Sheng, Shuang Zhou, Ting Yang, Ling-Yue Ma, Ying Zhou, Yi-Min Cui

Registry-linked trialOpen access · bronzeAbstract readComparative StudyMeta-AnalysisReview
In one paragraph

Synthesis in British journal of clinical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04855513 (Prevention of Pre-eclampsia Using Metformin), which is not on this map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04855513 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial

TypeinterventionalSponsorHamad Medical CorporationRan2022 to 2023Enrolled414ConditionsPreeclampsia, Preeclampsia Severe, High Risk Pregnancy, EclampsiaArmsMetformin
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Evaluation of Preeclampsia Results after Use of Metformin in Gestation: Systematic Review and Meta-analysis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2018
    Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Metformin decreases hyaluronan synthesis by vascular smooth muscle cells.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Li-Ping ZhaoDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Xiao-Yan ShengDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Shuang ZhouDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Ting YangDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Ling-Yue MaDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Ying ZhouDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Yi-Min CuiDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Peking University First Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present meta-analysis was to determine the efficacy and safety of metformin for the treatment of women with gestational diabetes mellitus (GDM). We searched databases, including PubMed, Embase and the Cochrane Central Register of Controlled Trials, for randomized controlled trials (RCTs) comparing metformin and insulin treatments in women with GDM. We carried out statistical analyses using RevMan 2011 and used the Grading of Recommendations, Assessment, Development, and Evaluations profiler to rate the quality of evidence of the primary outcomes. We analysed eight studies involving 1592 subjects. Meta-analysis of the RCTs showed that metformin had statistically significant effects on pregnancy-induced hypertension [PIH; risk ratio (RR) 0.54; 95% confidence interval (CI) 0.31, 0.91]. However, its effects on neonatal hypoglycaemia (RR 0.80; 95% CI 0.62, 1.02), rate of large-for-gestational age infants (RR 0.77; 95% CI 0.55, 1.08), respiratory distress syndrome (RR 1.26; 95% CI 0.67, 2.37), phototherapy (RR 0.94; 95% CI 0.67, 1.31) and perinatal death (RR 1.01; 95% CI 0.11, 9.53) were not significant. Our analyses suggest that there is no clinically relevant difference in efficacy or safety between metformin and insulin; however, metformin may be a good choice for GDM because of the lower risk of PIH. The advantages of metformin in terms of glycaemic control, PIH incidence and gestational age at birth are unclear, and should be verified in further trials.

Indexed as

Diabetes, GestationalFemaleHumansHypertension, Pregnancy-InducedInsulinMetforminPregnancyRandomized Controlled Trials as TopicInsulinMetformingestational diabetesinsulinmetforminrandomized controlled trial

Identifiers

PMID25925501
PMCPMC4631195
OpenAlexW2053669970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.